Supreme Court Warns Patanjali On Ads Targeting Allopathic Medicines

Representational image.

New Delhi: During the consideration of a petition filed by the Indian Medical Association, the Supreme Court on Tuesday warned Patanjali Ayurved against publishing misleading advertisements targeting allopathic medicines. A bench of Justices Ahsanuddin Amanullah and Prashant Kumar Mishra said Patanjali that it would be fined Rs 1 crore if a false claim is made that its products can “cure” certain diseases.

The court directed Patanjali Ayurved to stop publishing any such misleading advertisements in the future. The court said that it must ensure that it refrains from making casual statements in the press, India Today reported.

The petition alleges that Patanjali’s misleading advertisements disparage allopathy and make false claims about curing certain diseases.

IMA has further contended that the claims by Patanjali are unverified and are in direct violation of laws such as the Drugs and Other Magic Remedies Act, 1954, and the Consumer Protection Act, 2019.

The court also asked the Centre government to come out with workable recommendations in this regard and slated the hearing for February 5, 2024.